Omnicell

Youtube Subscribe

Open: 68.03 Close: 67.42 Change: -0.61

You don't have time to read all about Omnicell Stock. An AI summarizes all the information for you.

How much time have you spent trying to decide whether investing in Omnicell? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Omnicell are: Omnicell, earnings, …

Concept Map

Semantic Network

Stock Summary

Omnicell, Inc. provides medication management solutions and adherence tools for healthcare systems and pharmacies. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system. It also provides IV comp.

Today's Summary

TheStreet raised Omnicella from a “d+” rating to a ‘c- Omnicell (OMCL) reported earnings 30 days ago. Central fill pharmacy automation market to see booming growth.

Today's News

Zacks Research: FY2025 earnings per share estimate for Omnicell is $0.52 per share. The consensus estimate for the company’s current full-year earnings is $70.00. TheStreet raised Omnicella from a “d+” rating to a ‘c- Omnicell (OMCL) reported earnings 30 days ago. New Acquisitions Aid Growth, Cost Woes Stay. Omnicell (OMCL) reported earnings 30 days ago. The company is the world leader in pharmacy robotics, and were dedicated to becoming doctors and nurses most trusted partner. Senior Information Developer/ Product Writer - Remote. Senior Financial Analyst - REMOTE Omnicell, Inc. Job In Cranberry, PA Or Remote. Central fill pharmacy automation market to see booming growth 2023-2030 with industry demand, market future scope, size, share. Central Fill Pharmacy Automation Market to see Booming Growth 2023 -2030. Omnicell (OMCL) delivered earnings and revenue surprises of 457.14% and 4.96% for the quarter ended March 2023. Investors are optimistic about the companys strong execution of strategies, disciplined cost management. Zacks: Omnicell delivered earnings and revenue surprises of 266.67% and 3.97% for the quarter ended December 2022. ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” fourth quarter 2022 investor letter. Manual IV Compounding – a Potential Recipe for Disaster? Omnicell Unveils Groundbreaking Robotic Compounding Technology in Winter 2022 Release. FDA Reaffirms Synthetic THC Compounds Are Schedule I Controlled Substances. Pharmacist-in-charge in Austin, Texas, United States. Omnicell is empowering health systems and pharmacies to radically transform the way they manage medications, so that they can achieve the vision of the Autonomous Pharmacy.

Stock Profile

"Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California."

Keywords

The game is changing. There is a new strategy to evaluate Omnicell fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Omnicell are: Omnicell, earnings, company, share, OMCL, pharmacy, quarter, and the most common words in the summary are: omnicell, job, pharmacy, stock, service, compound, management, . One of the sentences in the summary was: TheStreet raised Omnicella from a “d+” rating to a ‘c- Omnicell (OMCL) reported earnings 30 days ago. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #omnicell #job #pharmacy #stock #service #compound #management.

Read more →

Youtube Subscribe

---